Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)

NCT: NCT07640776 · NOT_YET_RECRUITING

NCT IDNCT07640776
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2031-06
SponsorAngiodynamics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study will evaluate the safety and effectiveness of using Irreversible Electroporation (IRE) for the treatment of symptomatic benign prostatic hyperplasia (BPH).

Frequently Asked Questions

What is Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)?

Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) is a clinical trial registered under NCT07640776. Current status: NOT_YET_RECRUITING.

What is the status of NCT07640776?

The current status of NCT07640776 (Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)) is: NOT_YET_RECRUITING.

When did Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) start?

Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH) started on 2026-09.

Related Devices

K161596Soft-Vu, Mariner, Accu-Vu and AngioOptic CathetersAngioDynamics, Inc. K162449Solero MTA System, Solero Microwave Tissue Ablation Applicator (14cm), Solero Microwave Tissue Ablation Applicator (19cm),Solero Microwave Tissue Ablation Applicator (29cm)AngioDynamics, Inc. K162914VenaCure EVLT NeverTouch Procedure KitAngioDynamics, Inc. K163141NAMIC ClearaCIL Contrast Injection LinesAngioDynamics, Inc. K163356Pulse* Spray Infusion System, Uni*Fuse Infusion SystemAngioDynamics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑